triacetin has been researched along with Atrophy in 1 studies
Triacetin: A triglyceride that is used as an antifungal agent.
triacetin : A triglyceride obtained by acetylation of the three hydroxy groups of glycerol. It has fungistatic properties (based on release of acetic acid) and has been used in the topical treatment of minor dermatophyte infections.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karlstad, MD | 1 |
| Killeffer, JA | 1 |
| Bailey, JW | 1 |
| DeMichele, SJ | 1 |
1 other study available for triacetin and Atrophy
| Article | Year |
|---|---|
Parenteral nutrition with short- and long-chain triglycerides: triacetin reduces atrophy of small and large bowel mucosa and improves protein metabolism in burned rats.
Topics: Animals; Atrophy; Burns; Disease Models, Animal; DNA; Energy Intake; Energy Metabolism; Fluid Therap | 1992 |